Gem Aromatics IPO Date, Price, GMP, Review, Allotment Details

Facebook
Reddit
Telegram
WhatsApp

Gem Aromatics IPO, a prominent manufacturer of essential oils, aroma chemicals, and value-added derivatives, is launching a ₹451.25 crore IPO through a book-building process from August 19 to 21, 2025, with shares priced between ₹309 and ₹325. The offering includes a ₹175 crore fresh issue and an offer-for-sale worth ₹276.25 crore by existing shareholders. Each lot consists of 46 shares, with a minimum investment of approximately ₹14,950. The company specializes in a broad product portfolio—mint and clove derivatives, phenol, and other synthetic and natural ingredients—serving diverse sectors such as oral care, cosmetics, pharmaceuticals, well-being, and personal care. In FY25, Gem Aromatics reported robust financials, including revenue of ₹503.95 crore and profit after tax of ₹53.38 crore, driven by high-quality R&D and customer relationships. Its proceeds will largely fund the repayment of borrowings, supporting balance sheet stability and future growth. The IPO is allocated across investor categories—35% to retail, 15% to NIIs, and 50% to institutional buyers.

Table of Contents

Gem Aromatics IPO Details

Gem Aromatics IPO Market Lot

Gem Aromatics IPO Dates

Promoters of Gem Aromatics IPO

Vipul Parekh, Kaksha Vipul Parekh, Yash Vipul Parekh & Parekh Family Trust.

About Gem Aromatics IPO

Gem Aromatics IPO a prominent player in the specialty ingredients sector, is launching a ₹451 crore IPO, with subscription open from August 19 to August 21, 2025, and shares priced between ₹309 and ₹325. The offering comprises a ₹175 crore fresh issue and an offer for sale by promoters and existing investors, structuring a balanced capital mobilization. The minimum lot size is 46 shares, translating to an investment of approximately ₹14,950 at the upper price band, and the listing is expected around August 26, 2025. Gem Aromatics, established in 1997, manufactures a diverse range of products—mint and clove derivatives, phenol, and other synthetic and natural aroma chemicals—serving key industries such as oral care, cosmetics, pharmaceuticals, and wellness. In FY 2025, the company posted strong financials with revenue rising to ₹503.95 crore and net profit increasing to ₹53.38 crore, reflecting consistent growth. The fresh capital will be used mainly for debt repayment, reinforcing financial stability, with the remainder allocated for corporate usage. Anchored by its robust R&D capabilities, strategic manufacturing facilities, and long-standing client relationships, this IPO positions Gem Aromatics as a solid growth opportunity in the ingredients space.

Gem Aromatics IPO Company Financial Report

Amount ₹ in Crores.

Period Ended
Revenue
Expense
Profit After Tax
Assets
2023
376.50
314.21
39.22
297.84
2024
452.45
378.10
50.10
391.75
2025
503.95
425.41
53.38
534.51
Gem Aromatics IPO Valuation
KPI Values
ROE (Return on Equity) 19.01%
ROCE (Return on Capital Employed) 16.99%
EBITDA Margin 18.16%
PAT Margin 8.46%
Debt-to-Equity Ratio 0.84
Earnings Per Share (EPS) ₹9.01 (Basic)
Price-to-Earnings (P/E) Ratio N/A
Return on Net Worth (RoNW) 19.01%
Net Asset Value (NAV) ₹47.39
IPO Lead Managers
  • Motilal Oswal Investment Advisors Ltd.
Objects of the Issue
  • Prepayment and/or repayment, in full or in part, of all or a portion of certain outstanding borrowings availed by our Company and our Subsidiary, Krystal Ingredients Private Limited; and
  • General Corporate Purposes
Registrar Contact Details

KFin Technologies Limited
Phone: 04067162222, 04079611000
Email: atpl.ipo@kfintech.com
Website: https://kosmic.kfintech.com/ipostatus/

Company Contact Details

Gem Aromatics
A/410, Kailas Complex, Vikhroli Powai Link Road, Park Site,
Vikhroli (W), Mumbai, Maharashtra, 400079
Phone: +91 22 25185231
Email: secretarial@gemaromatics.in
Website: http://www.gemaromatics.com/

Leave a Reply

Your email address will not be published. Required fields are marked *

Picture of Team IPO Researcher

Team IPO Researcher

An IPO market specialist with extensive knowledge of stock markets, research, and equity strategies. He brings sharp insights into upcoming IPOs, investor participation, grey market premium (GMP) movements, and post-listing trends, delivering in-depth reviews, recommendations, and technical evaluations.

Disclaimer: This content is provided strictly for educational and informational purposes. The securities or investments mentioned are not to be considered as investment advice or recommendations. The Investors are advised to do their own research or connect with a financial advisor before making any investment decisions.